Trials / Sponsors / Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of PRA052 in Healthy Volunteers Healthy | Phase 1 | 2022-11-07 |
| Completed | Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023 Healthy | Phase 1 | 2022-04-06 |
| Active Not Recruiting | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associa Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease | Phase 2 | 2022-03-29 |
| Completed | A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn Crohn Disease | Phase 2 | 2021-07-28 |
| Completed | A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely A Ulcerative Colitis | Phase 2 | 2021-07-14 |
| Completed | A Study of PRA023 in Healthy Volunteers Healthy | Phase 1 | 2020-12-15 |